Testing a panel of 12 single-nucleotide polymorphisms may help identify people at increased risk of atrial fibrillation and stroke, according to a recent study by researchers from the Lund University in Malmö, Sweden, the Broad Institute, Harvard Medical School, Cambridge, MA, and Quest Diagnostics. The award-winning poster may be accessed by ACC attendees through the ACC.14 Attendee Portal.
Compared to the general population, a woman with a confirmed BRCA1 or BRCA2 mutation is at greater risk of developing cancer during her lifetime—up to an 85% risk of breast cancer and up to a 40% risk of ovarian cancer. Her children, siblings and parents have a 50% chance of having the same autosomal dominant mutation and facing comparable risks.
Visit Our New Upcoming Events Center For Event Details
WebinarsView All Webinars >
The immediate past chair of the U.S. Preventive Services Task Force, Michael L. LeFevre, MD, MSPH, explains the role and processes of the U.S. Preventive... Read more
Dr. Levenson helps attendees understand the potential factors causing inflammation, reviews the critical risk factors that can lead to inflammation and discusses the biomarkers and... Read more
Gerard Abate, MD, Quest Diagnostics medical director discusses the impact of personalized medicine on cardiovascular diagnostics. Read more
Expert InsightsView All Expert Insights >
Knowing the score: Identifying patients at high risk of liver fibrosis from Non-Alcoholic Fatty Liver Disease (NAFLD)
PublicationsView All Publications >
Nassar A, Cohen C, Zhou W, Lynch KA, Barker EA, Vanderbilt BL, Thompson J, Heyman ER, Olson A, Lange H, Siddiqui MT.Bandino JP, Kazlouskaya V, Ergin S, Moles-Proveda P, Cleaver NJ, Kabigting FD, Shackelton JB, Thieu K
J Cutan Pathol 2015
Determination of HIV-1 coreceptor tropism using proviral DNA in women before and after viral suppression.
Nassar A, Cohen C, Zhou W, Lynch KA, Barker EA, Vanderbilt BL, Thompson J, Heyman ER, Olson A, Lange H, Siddiqui MT.Burger H, Weiser B, Gao W, Anastos K, Young M
AIDS Res Ther 2015;12:11
Use of a picosecond pulse duration laser with specialized optic for treatment of facial acne scarring.
Nassar A, Cohen C, Zhou W, Lynch KA, Barker EA, Vanderbilt BL, Thompson J, Heyman ER, Olson A, Lange H, Siddiqui MT.Brauer JA, Kazlouskaya Y, Alabdulrazzaq H, Bae YS, Bernstein LJ, Anolik R, Geronemus RG
JAMA Dermatol 2015;151:278-284